The phase 3 STRIDE-10 trial evaluated the safety and immunogenicity of V116 in pneumococcal vaccine-naive adults 50 years of age and older.
Immunization
— DRUG MONOGRAPHS BY SUBSECTION —
News and Features
More than half are very likely to get vaccinated; vaccination rates higher for those who perceive RSV as serious
Findings based on review of national versus WHO guidelines
The CDC Advisory Committee on Immunization Practices February meeting covered vaccinations for COVID-19, influenza, RSV, and pneumococcal infections.
A regulatory decision is expected on February 14, 2025.
Patients with accelerated HBV vaccination who experience seroconversion might be eligible to receive a kidney transplant from a hepatitis B-positive donor.
Greatest increase in on-time vaccination seen for children with more than $75,000 in annual family income.
SuVax is a subunit protein vaccine of recombinantly expressed Sudan ebolavirus glycoprotein.
Vaccination found to be safe and induces polyclonal immune responses against vaccine targets.
The randomized, double-blind, placebo-controlled MONeT trial evaluated the immunogenicity and safety of Abrysvo in adults 18 years and older at risk of RSV-associated disease.
Authors say findings still emphasize the importance of viewing AI tools as complementary resources when seeking medical information
Odds of invasive mechanical ventilation, death significantly increased for those with RSV versus vaccinated COVID, flu
First prescription smartphone app is approved for major depressive disorder; Novel blood test to detect TBI; Zevtera has been approved for bloodstream infections; The Mpox vaccine is now commercially available; Algorithm cleared for LVEF detection.
The commercial launch of Jynneos allows health care providers to order the vaccine and make it available to patients in physician offices and pharmacies, in addition to public health clinics.
While the current threat to the public is low, the CDC said it continues to monitor H5N1 viruses nationally.
Men, Hispanic adults have lower odds of receiving the vaccine.
Mpox, formerly known as monkeypox, is spread through close personal contact.
Second booster dose resulted in 123,869 fewer hospitalizations and 5,524 fewer deaths versus single-dose campaign.
The rate of routine vaccination in the US has dropped below the 95% needed to provide protection for the general population. Here are some tips to help reduce anxiety around vaccinations.
The phase 3 NextCOVE study compared the safety, reactogenicity, relative vaccine efficacy and immunogenicity of mRNA-1283 to Moderna’s licensed COVID-19 vaccine, Spikevax.
- Loading...
